Literature DB >> 1473252

Analysis of tobacco-specific N-nitrosamines in indoor air.

K D Brunnemann1, J E Cox, D Hoffmann.   

Abstract

A method was developed and applied for the assessment of tobacco-specific N-nitrosamines (TSNA) in indoor air polluted with tobacco smoke. Air samples were collected on Cambridge filters treated with 0.01 M potassium bisulfate, extracted with dichloromethane and enriched by column chromatography. The fraction containing the TSNA was concentrated and placed on a thermal desorption cartridge packed with Tenax GR. The sample was thermally desorbed and analyzed by capillary GC using a thermal energy analyzer. When the method was applied in a test laboratory in which one, two and four cigarettes were smoked during 30 min, linearity was observed. Field studies included sampling in bars, restaurants and trains. The concentration of N'-nitrosonornicotine (NNN) ranged from not detected to 23 pg/l, that of N'-nitrosoanatabine ranged from not detected to 9 pg/l, while 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) was detected in concentrations ranging from 1 to 29 pg/l. This means an exposure to NNN and NNK of 0.1-0.3 cigarette equivalents. Thus, non-smokers can be exposed to highly carcinogenic TSNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1473252     DOI: 10.1093/carcin/13.12.2415

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

1.  Second-hand smoke in cars: How did the "23 times more toxic" myth turn into fact?

Authors:  Ross MacKenzie; Becky Freeman
Journal:  CMAJ       Date:  2010-04-12       Impact factor: 8.262

Review 2.  Biomarkers of exposure to new and emerging tobacco delivery products.

Authors:  Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

3.  Secondhand smoke in waterpipe tobacco venues in Istanbul, Moscow, and Cairo.

Authors:  Katherine A Moon; Hoda Magid; Christine Torrey; Ana M Rule; Jacqueline Ferguson; Jolie Susan; Zhuolu Sun; Salahaddin Abubaker; Vladimir Levshin; Aslı Çarkoğlu; Ghada Nasr Radwan; Maha El-Rabbat; Joanna Cohen; Paul Strickland; Ana Navas-Acien; Patrick N Breysse
Journal:  Environ Res       Date:  2015-10       Impact factor: 6.498

4.  Indoor Air Quality and Passive E-cigarette Aerosol Exposures in Vape-Shops.

Authors:  Yeongkwon Son; Daniel P Giovenco; Cristine Delnevo; Andrey Khlystov; Vera Samburova; Qingyu Meng
Journal:  Nicotine Tob Res       Date:  2020-10-08       Impact factor: 4.244

5.  Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke.

Authors:  Ghada Radwan; Stephen S Hecht; Steven G Carmella; Christopher A Loffredo
Journal:  Nicotine Tob Res       Date:  2012-05-09       Impact factor: 4.244

Review 6.  Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke.

Authors:  S S Hecht
Journal:  Tob Control       Date:  2004-03       Impact factor: 7.552

7.  Identification and validation of a cigarette smoke-related five-gene signature as a prognostic biomarker in kidney renal clear cell carcinoma.

Authors:  Yefei Huang; Qinzhi Wang; Yu Tang; Zixuan Liu; Guixiang Sun; Zhaojun Lu; Yansu Chen
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.379

Review 8.  Environmental monitoring of secondhand smoke exposure.

Authors:  Benjamin J Apelberg; Lisa M Hepp; Erika Avila-Tang; Lara Gundel; S Katharine Hammond; Melbourne F Hovell; Andrew Hyland; Neil E Klepeis; Camille C Madsen; Ana Navas-Acien; James Repace; Jonathan M Samet; Patrick N Breysse
Journal:  Tob Control       Date:  2012-09-04       Impact factor: 7.552

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.